Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 199
Filter
1.
J Cutan Pathol ; 51(6): 403-406, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38419370

ABSTRACT

Cutaneous pseudolymphomas are a wide group of diseases mimicking cutaneous lymphoma. They comprise several skin conditions with different etiopathogenesis, clinical-pathological features, and prognosis, which may occur in the absence of an identifiable trigger factor or after administration of medications or vaccinations, tattoos, infections, or arthropod bites. They present with different manifestations: from solitary to regionally clustered lesions, up to generalized distribution and, in rare cases, erythroderma. They persist variably, from weeks to years, and resolve spontaneously or after antibiotics, but may recur in some cases. CD30+ T-cell pseudolymphomas are characterized by the presence of large, activated lymphoid cells, generally in response to viral infections, arthropod assault reactions, and drug eruptions. Stenotrophomonas maltophilia is a ubiquitous Gram-negative bacillus responsible for opportunistic infections in immunocompromised patients. Infection of intact skin in immunocompetent patients is particularly rare. Here, we report a case of a man presenting an isolated nodule histopathologically mimicking a primary cutaneous CD30+ T-cell lymphoproliferative disorder.


Subject(s)
Lymphoproliferative Disorders , Pseudolymphoma , Stenotrophomonas maltophilia , Humans , Stenotrophomonas maltophilia/isolation & purification , Male , Lymphoproliferative Disorders/pathology , Lymphoproliferative Disorders/microbiology , Lymphoproliferative Disorders/diagnosis , Pseudolymphoma/pathology , Pseudolymphoma/diagnosis , Pseudolymphoma/microbiology , Pseudolymphoma/immunology , Ki-1 Antigen/metabolism , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pathology , Diagnosis, Differential , T-Lymphocytes/immunology , T-Lymphocytes/pathology , Skin Diseases, Bacterial/pathology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/immunology , Middle Aged , Immunocompetence
3.
Proc Natl Acad Sci U S A ; 119(32): e2111726119, 2022 08 09.
Article in English | MEDLINE | ID: mdl-35914162

ABSTRACT

A large number of neutrophils infiltrate the lymph node (LN) within 4 h after Staphylococcus aureus skin infection (4 h postinfection [hpi]) and prevent systemic S. aureus dissemination. It is not clear how infection in the skin can remotely and effectively recruit neutrophils to the LN. Here, we found that lymphatic vessel occlusion substantially reduced neutrophil recruitment to the LN. Lymphatic vessels effectively transported bacteria and proinflammatory chemokines (i.e., Chemokine [C-X-C motif] motif 1 [CXCL1] and CXCL2) to the LN. However, in the absence of lymph flow, S. aureus alone in the LN was insufficient to recruit neutrophils to the LN at 4 hpi. Instead, lymph flow facilitated the earliest neutrophil recruitment to the LN by delivering chemokines (i.e., CXCL1, CXCL2) from the site of infection. Lymphatic dysfunction is often found during inflammation. During oxazolone (OX)-induced skin inflammation, CXCL1/2 in the LN was reduced after infection. The interrupted LN conduits further disrupted the flow of lymph and impeded its communication with high endothelial venules (HEVs), resulting in impaired neutrophil migration. The impaired neutrophil interaction with bacteria contributed to persistent infection in the LN. Our studies showed that both the flow of lymph from lymphatic vessels to the LN and the distribution of lymph in the LN are critical to ensure optimal neutrophil migration and timely innate immune protection in S. aureus infection.


Subject(s)
Chemokines , Neutrophil Infiltration , Skin Diseases, Bacterial , Staphylococcal Infections , Animals , Chemokines/immunology , Immunity, Innate , Inflammation/pathology , Lymph/immunology , Lymph Nodes/cytology , Mice , Mice, Inbred C57BL , Neutrophils/cytology , Skin Diseases, Bacterial/immunology , Staphylococcal Infections/immunology , Staphylococcus aureus
4.
Proc Natl Acad Sci U S A ; 119(25): e2116027119, 2022 06 21.
Article in English | MEDLINE | ID: mdl-35704759

ABSTRACT

The epidermis is the outermost layer of the skin and the body's primary barrier to external pathogens; however, the early epidermal immune response remains to be mechanistically understood. We show that the chemokine CXCL14, produced by epidermal keratinocytes, exhibits robust circadian fluctuations and initiates innate immunity. Clearance of the skin pathogen Staphylococcus aureus in nocturnal mice was associated with CXCL14 expression, which was high during subjective daytime and low at night. In contrast, in marmosets, a diurnal primate, circadian CXCL14 expression was reversed. Rhythmically expressed CXCL14 binds to S. aureus DNA and induces inflammatory cytokine production by activating Toll-like receptor (TLR)9-dependent innate pathways in dendritic cells and macrophages underneath the epidermis. CXCL14 also promoted phagocytosis by macrophages in a TLR9-independent manner. These data indicate that circadian production of the epidermal chemokine CXCL14 rhythmically suppresses skin bacterial proliferation in mammals by activating the innate immune system.


Subject(s)
Epidermis , Immunity, Innate , Skin Diseases, Bacterial , Animals , Chemokines, CXC/genetics , Chemokines, CXC/immunology , Circadian Clocks/immunology , Epidermis/immunology , Immunity, Innate/genetics , Immunity, Innate/immunology , Keratinocytes/immunology , Mammals , Mice , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/metabolism , Staphylococcal Infections/immunology , Staphylococcus aureus/immunology
5.
J Clin Invest ; 131(2)2021 01 19.
Article in English | MEDLINE | ID: mdl-33211671

ABSTRACT

TH17 cell subpopulations have been defined that contribute to inflammation and homeostasis, yet the characteristics of TH17 cells that contribute to host defense against infection are not clear. To elucidate the antimicrobial machinery of the TH17 subset, we studied the response to Cutibacterium acnes, a skin commensal that is resistant to IL-26, the only known TH17-secreted protein with direct antimicrobial activity. We generated C. acnes-specific antimicrobial TH17 clones (AMTH17) with varying antimicrobial activity against C. acnes, which we correlated by RNA sequencing to the expression of transcripts encoding proteins that contribute to antimicrobial activity. Additionally, we validated that AMTH17-mediated killing of C. acnes and bacterial pathogens was dependent on the secretion of granulysin, granzyme B, perforin, and histone H2B. We found that AMTH17 cells can release fibrous structures composed of DNA decorated with histone H2B that entangle C. acnes that we call T cell extracellular traps (TETs). Within acne lesions, H2B and IL-17 colocalized in CD4+ T cells, in proximity to TETs in the extracellular space composed of DNA decorated with H2B. This study identifies a functionally distinct subpopulation of TH17 cells with an ability to form TETs containing secreted antimicrobial proteins that capture and kill bacteria.


Subject(s)
Acne Vulgaris/immunology , Extracellular Traps/immunology , Propionibacteriaceae/immunology , Skin Diseases, Bacterial/immunology , Th17 Cells/immunology , Acne Vulgaris/microbiology , Humans , RNA-Seq , Skin Diseases, Bacterial/microbiology
6.
Front Immunol ; 11: 601584, 2020.
Article in English | MEDLINE | ID: mdl-33224153

ABSTRACT

Introduction: Macrophage expressed gene 1 (MPEG1) is highly expressed in macrophages and other phagocytes. The gene encodes a bactericidal pore-forming protein, dubbed Perforin-2. Structural-, animal-, and cell-based studies have established that perforin-2 facilitates the destruction of phagocytosed microbes upon its activation within acidic phagosomes. Relative to wild-type controls, Mpeg1 knockout mice suffer significantly higher mortality rates when challenged with gram-negative or -positive pathogens. Only four variants of MPEG1 have been functionally characterized, each in association with pulmonary infections. Here we report a new MPEG1 non-sense variant in a patient with the a newly described association with persistent polymicrobial infections of the skin and soft tissue. Case Description: A young adult female patient was evaluated for recurrent abscesses and cellulitis of the breast and demonstrated a heterozygous, rare variant in MPEG1 p.Tyr430*. Multiple courses of broad-spectrum antimicrobials and surgical incision and drainage failed to resolve the infection. Functional studies revealed that the truncation variant resulted in significantly reduced capacity of the patient's phagocytes to kill intracellular bacteria. Patient-derived macrophages responded to interferon gamma (IFN-γ) by significantly increasing the expression of MPEG1. IFN-γ treatment supported perforin-2 dependent bactericidal activity and wound healing. Conclusions: This case expands the phenotype of MPEG1 deficiency to include severe skin and soft tissue infection. We showed that haploinsufficiency of perforin-2 reduced the bactericidal capacity of human phagocytes. Interferon-gamma therapy increases expression of perforin-2, which may compensate for such variants. Thus, treatment with IFN-γ could help prevent infections.


Subject(s)
Candidiasis, Cutaneous/genetics , Coinfection/genetics , Haploinsufficiency , Immunity, Innate/genetics , Membrane Proteins/genetics , Phagocytes/immunology , Pore Forming Cytotoxic Proteins/genetics , Skin Diseases, Bacterial/genetics , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/immunology , Candidiasis, Cutaneous/microbiology , Coinfection/drug therapy , Coinfection/immunology , Coinfection/microbiology , Female , Genetic Predisposition to Disease , Humans , Immunity, Innate/drug effects , Interferon-gamma/therapeutic use , Phagocytes/drug effects , Phagocytes/microbiology , Phenotype , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/microbiology , Treatment Outcome , Young Adult
7.
Diabetes Metab Syndr ; 14(6): 1889-1894, 2020.
Article in English | MEDLINE | ID: mdl-33002780

ABSTRACT

BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes predisposes to infections through alterations in innate and acquired immune defenses. Outcomes of infection are worse in people with uncontrolled diabetes, and infection can worsen hyperglycemia in hitherto well controlled diabetes (bidirectional relationship). Diabetes does not increase the risk of infection with COVID-19 per se, but predisposes to severe disease and poor outcomes. COVID-19 has also been linked to deterioration of glycemic control as well as new-onset diabetes. CONCLUSIONS: Clinicians caring for people with diabetes should be aware of the increased risk of infections in this population, as well as the possibility of worsening hyperglycemia. A holistic approach with frequent monitoring of blood glucose levels and appropriate titration of medications, along with close attention to nutritional status, is essential to ensure the best possible outcomes.


Subject(s)
COVID-19/epidemiology , Diabetes Mellitus/epidemiology , Tuberculosis, Pulmonary/epidemiology , Adaptive Immunity/immunology , Blood Glucose/metabolism , COVID-19/immunology , COVID-19/metabolism , Diabetes Mellitus/immunology , Diabetes Mellitus/metabolism , Glycemic Control , Humans , Immunity, Innate/immunology , India/epidemiology , Infections/epidemiology , Infections/immunology , Infections/metabolism , Reproductive Tract Infections/epidemiology , Reproductive Tract Infections/immunology , Reproductive Tract Infections/metabolism , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/immunology , Respiratory Tract Infections/metabolism , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/metabolism , Soft Tissue Infections/epidemiology , Soft Tissue Infections/immunology , Soft Tissue Infections/metabolism , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/metabolism , Urinary Tract Infections/epidemiology , Urinary Tract Infections/immunology , Urinary Tract Infections/metabolism
8.
Ann Clin Microbiol Antimicrob ; 19(1): 46, 2020 Oct 08.
Article in English | MEDLINE | ID: mdl-33032608

ABSTRACT

BACKGROUND: Infections were the primary cause of death (34.3-55.5%) in patients with pemphigus. Skin was usually the origin of infections. The study aimed to explore features and associated factors of bacterial skin infections (BSIs) in inpatients with pemphigus. METHODS: One hundred and seventy-seven inpatients with pemphigus hospitalizing from November 2014 to April 2019 were continuously recruited through Peking University First Hospital's inpatient records inpatients with pemphigus hospitalizing from November 2014 to April 2019 were continuously recruited through Peking University First Hospital's inpatient records. Then, we retrieved the clinical and laboratory data to explore the characteristics and associated factors of BSIs. RESULTS: Of patients enrolled, pemphigus vulgaris (PV, n = 142) and pemphigus foliaceus (PF, n = 9) were most common, followed by pemphigus erythematosus (PE, n = 25) and pemphigus vegetans (Pveg, n = 1). Eighty-seven of 177 (49.2%) inpatients developed BSIs, and they had a longer length of stay compared with inpatients without BSIs (median: 18.9 vs. 14.1 days, p = 0.008). Staphylococcus aureus was the most common bacteria (71.3%, 62/87) and highly resistant to penicillin (91.9%, 57/62). Higher levels of anti-Dsg1 autoantibodies (> 124.2 U/mL) (p < 0.001, odds ratio [OR] = 3.564, 95% confidence interval [CI]: 1.784-7.123) and anti-Dsg3 autoantibodies (> 169.5 U/mL) (p = 0.03, OR = 2.074, 95% CI: 1.084-3.969) were underlying risk factors of BSIs when analyzed by binary regression analysis. As for Gram's stain of bacteria, females had a lower rate of Gram-positive infections (p = 0.03). Patients using oral antibiotics (p = 0.05) had a higher rate of Gram-negative infections. Inpatients who were hospitalized in other hospitals within 2 weeks before the current admission had a higher rate of Gram-negative and co-infections (p = 0.03). CONCLUSIONS: Inpatients with pemphigus had a high incidence of BSIs. Some factors were associated with the susceptibility of BSIs and bacterial species.


Subject(s)
Pemphigus/immunology , Pemphigus/microbiology , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Autoantibodies/blood , China , Comorbidity , Drug Resistance, Multiple, Bacterial , Female , Humans , Inpatients , Male , Middle Aged , Retrospective Studies , Risk Factors , Young Adult
10.
Int J Mol Sci ; 21(14)2020 Jul 19.
Article in English | MEDLINE | ID: mdl-32707732

ABSTRACT

The skin is an important organ that acts as a physical barrier to the outer environment. It is rich in immune cells such as keratinocytes, Langerhans cells, mast cells, and T cells, which provide the first line of defense mechanisms against numerous pathogens by activating both the innate and adaptive response. Cutaneous immunological processes may be stimulated or suppressed by numerous plant extracts via their immunomodulatory properties. Several plants are rich in bioactive molecules; many of these exert antimicrobial, antiviral, and antifungal effects. The present study describes the impact of plant extracts on the modulation of skin immunity, and their antimicrobial effects against selected skin invaders. Plant products remain valuable counterparts to modern pharmaceuticals and may be used to alleviate numerous skin disorders, including infected wounds, herpes, and tineas.


Subject(s)
Anti-Infective Agents/administration & dosage , Plant Extracts/administration & dosage , Skin Diseases, Infectious/drug therapy , Skin Diseases, Infectious/microbiology , Dermatomycoses/drug therapy , Dermatomycoses/immunology , Dermatomycoses/microbiology , Drug Synergism , Humans , Immunologic Factors/administration & dosage , Plants, Medicinal/chemistry , Skin/drug effects , Skin/immunology , Skin/microbiology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Infectious/immunology , Virus Diseases/drug therapy , Virus Diseases/immunology , Virus Diseases/virology
11.
PLoS One ; 15(4): e0230782, 2020.
Article in English | MEDLINE | ID: mdl-32294093

ABSTRACT

Understanding immune responses to native antigens in response to natural infections can lead to improved approaches to vaccination. This study sought to characterize the humoral immune response to anthrax toxin components, capsule and spore antigens in individuals (n = 46) from the Kayseri and Malatya regions of Turkey who had recovered from mild or severe forms of cutaneous anthrax infection, compared to regional healthy controls (n = 20). IgG antibodies to each toxin component, the poly-γ-D-glutamic acid capsule, the Bacillus collagen-like protein of anthracis (BclA) spore antigen, and the spore carbohydrate anthrose, were detected in the cases, with anthrax toxin neutralization and responses to Protective Antigen (PA) and Lethal Factor (LF) being higher following severe forms of the disease. Significant correlative relationships among responses to PA, LF, Edema Factor (EF) and capsule were observed among the cases. Though some regional control sera exhibited binding to a subset of the tested antigens, these samples did not neutralize anthrax toxins and lacked correlative relationships among antigen binding specificities observed in the cases. Comparison of serum binding to overlapping decapeptides covering the entire length of PA, LF and EF proteins in 26 cases compared to 8 regional controls revealed that anthrax toxin-neutralizing antibody responses elicited following natural cutaneous anthrax infection are directed to conformational epitopes. These studies support the concept of vaccination approaches that preserve conformational epitopes.


Subject(s)
Anthrax/immunology , Antibodies, Bacterial/immunology , Antibodies, Neutralizing/immunology , Antigens, Bacterial/immunology , Bacterial Toxins/immunology , Epitopes/immunology , Skin Diseases, Bacterial/immunology , Adult , Anthrax Vaccines/immunology , Antibody Specificity/immunology , Bacillus anthracis/immunology , Female , Humans , Immunity, Humoral/immunology , Immunoglobulin G/immunology , Male , Middle Aged , Neutralization Tests/methods , Turkey , Young Adult
12.
J Cosmet Dermatol ; 19(5): 1039-1043, 2020 May.
Article in English | MEDLINE | ID: mdl-32162464

ABSTRACT

BACKGROUND: The human skin microbiome is represented by bacteria, fungi, viruses, and mites. AIMS: Every human being possess their own unique skin microbiome because intrinsic and environmental factors have a significant impact on the quality and quantity of microorganism. Every site of the body is a separate microbial niche. PATIENTS: The feet are one of the most unique and heterogeneous microbial niches of human body with areas that differ by skin thickness, anatomical features, distribution of sweat glands, pH, and the availability of oxygen. RESULTS: Healthy skin of the foot is inhabited by Corynebacteriaceae, Micrococcaceae, Propionibacteriaceae, Actinobacteria, Clostridiales, Lactobacillaceae, Streptococcaceae, Enterobacteriaceae, Moravellaceae, Neisseriaceae, Pastereullaceae, and Proteobacteria. The most common fungi present on the feet are Malassezzia, Cryptococcus, Aspergillus, Rhodotorula, Epicoccum, Saccharomyces, Candida, Epidermophyton Microsporum, and Trichophyton. CONCLUSIONS: The disturbance of the foot microbiome causes dysbiosis and may lead to pitted keratolysis, fungal, and viral infections or even to protothecosis.


Subject(s)
Dysbiosis/immunology , Foot Dermatoses/microbiology , Microbiota/immunology , Skin Diseases, Bacterial/microbiology , Skin/microbiology , Bacteria/immunology , Dysbiosis/microbiology , Foot , Foot Dermatoses/immunology , Fungi/immunology , Humans , Skin/immunology , Skin Diseases, Bacterial/immunology
15.
J Infect Dis ; 221(9): 1429-1437, 2020 04 07.
Article in English | MEDLINE | ID: mdl-31748786

ABSTRACT

Group A Streptococcus is a pathogen of global importance, but despite the ubiquity of group A Streptococcus infections, the relationship between infection, colonization, and immunity is still not completely understood. The M protein, encoded by the emm gene, is a major virulence factor and vaccine candidate and forms the basis of a number of classification systems. Longitudinal patterns of emm types collected from 457 Fijian schoolchildren over a 10-month period were analyzed. No evidence of tissue tropism was observed, and there was no apparent selective pressure or constraint of emm types. Patterns of emm type acquisition suggest limited, if any, modification of future infection based on infection history. Where impetigo is the dominant mode of transmission, circulating emm types either may not be constrained by ecological niches or population immunity to the M protein, or they may require several infections over a longer period of time to induce such immunity.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/immunology , Carrier Proteins/immunology , Skin Diseases, Bacterial/immunology , Streptococcal Infections/immunology , Streptococcus pyogenes/immunology , Adolescent , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Child , Child, Preschool , Female , Fiji/epidemiology , Humans , Longitudinal Studies , Male , Skin Diseases, Bacterial/epidemiology , Streptococcal Infections/epidemiology , Students
16.
J Clin Invest ; 130(3): 1417-1430, 2020 03 02.
Article in English | MEDLINE | ID: mdl-31805013

ABSTRACT

Epidermal growth factor receptor (EGFR) and MEK inhibitors (EGFRi/MEKi) are beneficial for the treatment of solid cancers but are frequently associated with severe therapy-limiting acneiform skin toxicities. The underlying molecular mechanisms are poorly understood. Using gene expression profiling we identified IL-36γ and IL-8 as candidate drivers of EGFRi/MEKi skin toxicity. We provide molecular and translational evidence that EGFRi/MEKi in concert with the skin commensal bacterium Cutibacterium acnes act synergistically to induce IL-36γ in keratinocytes and subsequently IL-8, leading to cutaneous neutrophilia. IL-36γ expression was the combined result of C. acnes-induced NF-κB activation and EGFRi/MEKi-mediated expression of the transcription factor Krüppel-like factor 4 (KLF4), due to the presence of both NF-κB and KLF4 binding sites in the human IL-36γ gene promoter. EGFRi/MEKi increased KLF4 expression by blockade of the EGFR/MEK/ERK pathway. These results provide an insight into understanding the pathological mechanism of the acneiform skin toxicities induced by EGFRi/MEKi and identify IL-36γ and the transcription factor KLF4 as potential therapeutic targets.


Subject(s)
ErbB Receptors/immunology , Interleukin-1/immunology , MAP Kinase Signaling System/immunology , Propionibacteriaceae/immunology , Skin Diseases, Bacterial/immunology , Animals , ErbB Receptors/genetics , Humans , Interleukin-1/genetics , Keratinocytes/immunology , Keratinocytes/microbiology , Keratinocytes/pathology , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors/genetics , Kruppel-Like Transcription Factors/immunology , MAP Kinase Signaling System/genetics , Mice , Mice, Knockout , NF-kappa B/genetics , NF-kappa B/immunology , Skin Diseases, Bacterial/genetics , Skin Diseases, Bacterial/pathology
17.
Dermatol Online J ; 25(6)2019 Jun 15.
Article in English | MEDLINE | ID: mdl-31329385

ABSTRACT

BACKGROUND: Malacoplakia is a rare acquired, infection-related granulomatous disorder, that may affect many systems, but typically occurs in the urinary tract. Cutaneous involvement is less prevalent, and most commonly presents with a perianal or genital region localization. Cutaneous malacoplakia is believed to be caused by an acquired bactericidal defect of macrophages in the setting of chronic infections and immunocompromised states. A diagnosis of cutaneous malacoplakia should be considered when encountering non-specific granulomatous lesions that are refractory to treatment. Histologic findings are marked by the presence of foamy macrophages containing the pathognomonic Michaelis-Gutman bodies. OBJECTIVES: The aim of this review is to discuss the current perspectives on the pathophysiology, clinical features, diagnosis, and treatment of this disease. We would also like to emphasize that the integration of clinical information, microscopic findings, and exclusion of other cutaneous granulomatous processes is necessary to accurately diagnose this exceedingly rare disease and provide opportunity for therapeutic intervention. PATIENTS/METHODS: Data for this work were collected from the published literature and textbooks. RESULTS: Combined surgical excision and protracted antibiotic courses appear to have the highest success rate. Antibiotics should be culture specific, but drugs that easily permeate the macrophages appear to be the best choice.


Subject(s)
Macrophages/pathology , Malacoplakia/pathology , Skin Diseases, Bacterial/pathology , Anti-Bacterial Agents/therapeutic use , Dermatologic Surgical Procedures , Granuloma/pathology , Humans , Macrophages/immunology , Malacoplakia/diagnosis , Malacoplakia/immunology , Malacoplakia/therapy , Phagocyte Bactericidal Dysfunction/immunology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/immunology , Skin Diseases, Bacterial/therapy
18.
Cell Host Microbe ; 25(6): 777-788.e8, 2019 Jun 12.
Article in English | MEDLINE | ID: mdl-31101494

ABSTRACT

Vitamin A deficiency increases susceptibility to skin infection. However, the mechanisms by which vitamin A regulates skin immunity remain unclear. Here, we show that resistin-like molecule α (RELMα), a small secreted cysteine-rich protein, is expressed by epidermal keratinocytes and sebocytes and serves as an antimicrobial protein that is required for vitamin-A-dependent resistance to skin infection. RELMα was induced by microbiota colonization of the murine skin, was bactericidal in vitro, and was protected against bacterial infection of the skin in vivo. RELMα expression required dietary vitamin A and was induced by the therapeutic vitamin A analog isotretinoin, which protected against skin infection in a RELMα-dependent manner. The RELM family member Resistin was expressed in human skin, was induced by vitamin A analogs, and killed skin bacteria, indicating a conserved function for RELM proteins in skin innate immunity. Our findings provide insight into how vitamin A promotes resistance to skin infection.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Immunologic Factors/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Skin Diseases, Bacterial/prevention & control , Skin/immunology , Vitamin A/metabolism , Animals , Cells, Cultured , Disease Models, Animal , Epithelial Cells/immunology , Epithelial Cells/metabolism , Humans , Mice , Resistin/metabolism , Skin Diseases, Bacterial/immunology , Transcriptional Activation/drug effects
19.
Acta Derm Venereol ; 99(10): 889-893, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31141157

ABSTRACT

Mycobacterium chelonae is a rapidly growing non-tuberculous mycobacterium, which causes infections of the human skin and soft tissue. Despite an increasing incidence of such infections, patients are often misdiagnosed. We report here 5 patients with cutaneous and/or soft tissue infection due to M. chelonae who were diagnosed and treated at our centre. Two of the 5 patients were on immunosuppressive treatment. While clinical presentations differed in each patient, all had a long history of skin lesions. In addition to careful history-taking, tissue biopsies were obtained for mycobacterial culture and histopathological examination. Culture-directed antibiotic therapy was initiated, which resulted in a slow, but continuous, healing of the lesions. In summary, M. chelonae infections are still relatively rare, but should be considered in both immunocompromised and immunocompetent patients with prolonged skin lesions resistant to standard antibiotic treatment. For diagnosis, tissue analysis for mycobacterial culture and histopathological examination, and once diagnosed, adequate antibiotic treatment, is needed.


Subject(s)
Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium chelonae/isolation & purification , Opportunistic Infections/microbiology , Skin Diseases, Bacterial/microbiology , Soft Tissue Infections/microbiology , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Female , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Male , Microbial Sensitivity Tests , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium chelonae/drug effects , Opportunistic Infections/diagnosis , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/immunology , Soft Tissue Infections/diagnosis , Soft Tissue Infections/drug therapy , Soft Tissue Infections/immunology , Treatment Outcome
20.
Trans R Soc Trop Med Hyg ; 113(7): 392-398, 2019 07 01.
Article in English | MEDLINE | ID: mdl-30989203

ABSTRACT

BACKGROUND: Actinomycetoma is a syndrome of the skin characterized by chronic inflammation and lesions with nodular grain-like structures. The most common aetiological agents are Nocardia brasiliensis and Actinomadura madurae. In response to infection with these organisms the body produces an inflammatory immune response in the skin. The aim of the present study was to determine the production of chemokines, pro-inflammatory cytokines, antimicrobial peptides and the expression of Toll-like receptors (TLRs) in keratinocytes infected by A. madurae. METHODS: A cell line of HaCaT keratinocytes was infected with A. madurae at a multiplicity of infection of 20:1 for 2 h and the samples were collected from 2 to 72 h post-infection. Intracellular replication of the bacterium was evaluated by counting of colony-forming units, the TLR expression and antimicrobial peptide production were assayed by confocal microscopy and chemokine and pro-inflammatory cytokine levels were determined by enzyme-linked immunosorbent assay. RESULTS: Early in the infection, A. madurae was able to achieve intracellular replication in keratinocytes, however, the cells eventually controlled the infection. In response to the infection, keratinocytes overexpressed TLR2 and TLR6, produced high concentrations of cytokines monocyte chemoattractant protein-1, interleukin 8, human ß-defensin-1, human ß-defensin-2 and LL37 and low levels of tumour necrosis factor α. CONCLUSIONS: The human keratinocytes contribute to the inflammatory process in response to A. madurae infection by overexpressing TLRs and producing chemokines, pro-inflammatory cytokines and antimicrobial peptides.


Subject(s)
Actinobacteria/pathogenicity , Inflammation/etiology , Keratinocytes/immunology , Actinobacteria/isolation & purification , Actinomadura , Cytokines/immunology , Cytokines/isolation & purification , Enzyme-Linked Immunosorbent Assay , Humans , Mycetoma/etiology , Mycetoma/physiopathology , Skin Diseases, Bacterial/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...